In short, while it is generally safe and often recommended, there are specific steps you must take to ensure these supplements work with your body rather than against it
M., Roux, J., Bariohay, B., Rouquet, T., & Baar, K
despite being taken as a daily pill rather than injection, it contains the same active ingredient and allegedly carries similar risks Mounjaro (tirzepatide): Manufactured by Eli Lilly and approved in May 2022, this medication works as a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, offering enhanced blood sugar control and weight loss effects but also allegedly causing severe gastrointestinal injuries similar to semaglutide products Trulicity (dulaglutide): Eli Lillys once-weekly GLP-1 injection approved in 2014 for type 2 diabetes
Among them were 1,467 women with type 2 diabetes
Since starting a GLP-1 through LifeMD, 32-year-old Julie C., tells Womans World that shes seen a major shift in her health and well-being